Medical Instruments & Supplies · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Envista Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get NVST alertsAmir Aghdaei is recorded as CEO at Envista Holdings Corp (NVST). Envista Holdings Corp reported in an 8-K filed April 15, 2024 that Amir Aghdaei resigned as director of the Board, effective May 1, 2024. The proxy statement of Envista Holdings Corp reports total compensation of $7,059,325 for Amir Aghdaei in fiscal 2023, including a base salary of $1,100,000. Disclosed compensation is on record for 7 fiscal years. Amir Aghdaei has spoken on 16 earnings calls across 1 company, most recently for Envista Holdings Corp on May 1, 2024. Envista Holdings Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Envista Holdings Corp includes Paul Keel (Chairman and Board Member), Andrew Chen (CIO), Mark Nance (General Counsel) and 7 others.
“Pursuant to that certain transition letter agreement entered into by and between Amir Aghdaei, the Company’s current President and Chief Executive Officer, and the Company, dated as of February 22, 2024 (the “Transition Agreement”), as of the Effective Date, Mr. Aghdaei will automatically be deemed to have resigned from his position as a director of the Board.”
“We appreciate you taking the time to join us today. Before we discuss our first quarter earnings, I would like to take this time to quickly discuss our leadership transition.”
“We appreciate you taking the time to join us today. Despite a volatile macro backdrop, we're making progress against our long-term strategic priorities. In line with our expectations, we finished 2023 with a modest sales decline for the full year and delivered an adjusted EBITDA margin of 18.1%.”
“We appreciate you taking the time to join us today. In the third quarter, we delivered positive core growth and an adjusted EBITDA margin of 19.6%.”
“We appreciate you taking the time to join us today. As anticipated, our performance in the second quarter accelerated as we continue to focus on partnering with dental professionals to digitize, personalize and democratize oral care.”
“We appreciate you taking the time to join us today. Despite a volatile macro backdrop, we continue to make progress against our long-term strategic priorities. As anticipated, the first quarter proved challenging with our core sales down 2.4%.”
Medical Instruments & Supplies · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Envista Holdings Corp (NVST) | President & CEO, until May 1, 2024 | $1,100,000 | $7,059,325 |
| 2022 | Envista Holdings Corp (NVST) | President & CEO, until May 1, 2024 | $1,100,000 | $8,523,732 |
| 2021 | Envista Holdings Corp (NVST) | President & CEO | $1,100,000 | $9,199,748 |
| 2020 | Envista Holdings Corp (NVST) | President & CEO | $1,007,981 | $7,370,894 |
| 2019 | Envista Holdings Corp (NVST) | President & CEO | $784,518 | $7,582,512 |
| 2018 | Envista Holdings Corp (NVST) | President & CEO | $608,615 | $6,599,157 |
| 2017 | Envista Holdings Corp (NVST) | President & CEO | $573,481 | $3,510,298 |